270 related articles for article (PubMed ID: 21943407)
1. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.
Meng W; Yamazaki T; Nishida Y; Hanagata N
BMC Biotechnol; 2011 Sep; 11():88. PubMed ID: 21943407
[TBL] [Abstract][Full Text] [Related]
2. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
Suwarti S; Yamazaki T; Svetlana C; Hanagata N
Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
[TBL] [Abstract][Full Text] [Related]
3. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.
Hanagata N
Int J Nanomedicine; 2012; 7():2181-95. PubMed ID: 22619554
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9.
Pohar J; Lainšček D; Kunšek A; Cajnko MM; Jerala R; Benčina M
Sci Rep; 2017 Nov; 7(1):14598. PubMed ID: 29097808
[TBL] [Abstract][Full Text] [Related]
5. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
[TBL] [Abstract][Full Text] [Related]
6. Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9.
Fehér K
Curr Protein Pept Sci; 2019; 20(11):1060-1068. PubMed ID: 31470785
[TBL] [Abstract][Full Text] [Related]
7. G-Quadruplex Structure Improves the Immunostimulatory Effects of CpG Oligonucleotides.
Hoshi K; Yamazaki T; Sugiyama Y; Tsukakoshi K; Tsugawa W; Sode K; Ikebukuro K
Nucleic Acid Ther; 2019 Aug; 29(4):224-229. PubMed ID: 30835633
[TBL] [Abstract][Full Text] [Related]
8. The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs.
Bjersing JL; Eriksson K; Tarkowski A; Collins LV
Inflammation; 2004 Feb; 28(1):39-51. PubMed ID: 15072229
[TBL] [Abstract][Full Text] [Related]
9. Binding mode of CpG oligodeoxynucleotides to nanoparticles regulates bifurcated cytokine induction via Toll-like receptor 9.
Chinnathambi S; Chen S; Ganesan S; Hanagata N
Sci Rep; 2012; 2():534. PubMed ID: 22837814
[TBL] [Abstract][Full Text] [Related]
10. Monomeric G-Quadruplex-Based CpG Oligodeoxynucleotides as Potent Toll-Like Receptor 9 Agonists.
Tu ATT; Hoshi K; Ikebukuro K; Hanagata N; Yamazaki T
Biomacromolecules; 2020 Sep; 21(9):3644-3657. PubMed ID: 32857497
[TBL] [Abstract][Full Text] [Related]
11. Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs.
Kim D; Jung J; Lee Y; Kwon HJ
Mol Immunol; 2011 Jul; 48(12-13):1494-504. PubMed ID: 21529949
[TBL] [Abstract][Full Text] [Related]
12. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
Linghua Z; Xingshan T; Fengzhen Z
Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448
[TBL] [Abstract][Full Text] [Related]
13. Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle.
Chu CY; Lee SC; Liu SS; Lin YM; Shen PC; Yu C; Lee KH; Zhao X; Lee JW
Nucleic Acid Ther; 2011 Oct; 21(5):323-32. PubMed ID: 21916610
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
Yu C; An M; Li M; Liu H
Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
Arunkumar N; Liu C; Hang H; Song W
Cell Mol Immunol; 2013 Jul; 10(4):360-72. PubMed ID: 23727784
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 9 regulates melanogenesis through NF-κB activation.
Sun L; Pan S; Yang Y; Sun J; Liang D; Wang X; Xie X; Hu J
Exp Biol Med (Maywood); 2016 Aug; 241(14):1497-504. PubMed ID: 27075928
[TBL] [Abstract][Full Text] [Related]
17. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9.
Pohar J; Lainšček D; Fukui R; Yamamoto C; Miyake K; Jerala R; Benčina M
J Immunol; 2015 Nov; 195(9):4396-405. PubMed ID: 26416273
[TBL] [Abstract][Full Text] [Related]
18. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
Front Immunol; 2019; 10():179. PubMed ID: 30800129
[TBL] [Abstract][Full Text] [Related]
19. Selectivity of Human TLR9 for Double CpG Motifs and Implications for the Recognition of Genomic DNA.
Pohar J; Yamamoto C; Fukui R; Cajnko MM; Miyake K; Jerala R; Benčina M
J Immunol; 2017 Mar; 198(5):2093-2104. PubMed ID: 28115525
[TBL] [Abstract][Full Text] [Related]
20. TLR9 mediates S. aureus killing inside osteoblasts via induction of oxidative stress.
Mohamed W; Domann E; Chakraborty T; Mannala G; Lips KS; Heiss C; Schnettler R; Alt V
BMC Microbiol; 2016 Oct; 16(1):230. PubMed ID: 27716055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
